Nanoparticles (NPs) are crucial in nanomedicine for drug delivery, imaging, and diagnostics. However, their cellular uptake and intracellular trafficking are critical for their efficacy and safety. This review discusses the various pathways by which NPs enter cells, including phagocytosis, pinocytosis, clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis. The physicochemical properties of NPs, such as size, shape, surface charge, and hydrophobicity, significantly influence their uptake mechanisms and intracellular fate. Smaller NPs (50 nm) are more efficiently internalized, while larger NPs may use different pathways. Positively charged NPs are internalized via macropinocytosis, while negatively charged NPs use clathrin- or caveolae-mediated endocytosis. Surface modifications, such as PEGylation, can enhance NP stability and targeting. The elasticity of NPs also affects their internalization, with stiffer NPs being more efficiently taken up. Intracellular trafficking of NPs involves endosomes, lysosomes, and autophagy, which determine their toxicity and therapeutic effectiveness. Understanding these processes is essential for designing safe and efficient nanomedicines. The review highlights the importance of optimizing NP properties to enhance their biological functions while minimizing cytotoxicity.Nanoparticles (NPs) are crucial in nanomedicine for drug delivery, imaging, and diagnostics. However, their cellular uptake and intracellular trafficking are critical for their efficacy and safety. This review discusses the various pathways by which NPs enter cells, including phagocytosis, pinocytosis, clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis. The physicochemical properties of NPs, such as size, shape, surface charge, and hydrophobicity, significantly influence their uptake mechanisms and intracellular fate. Smaller NPs (50 nm) are more efficiently internalized, while larger NPs may use different pathways. Positively charged NPs are internalized via macropinocytosis, while negatively charged NPs use clathrin- or caveolae-mediated endocytosis. Surface modifications, such as PEGylation, can enhance NP stability and targeting. The elasticity of NPs also affects their internalization, with stiffer NPs being more efficiently taken up. Intracellular trafficking of NPs involves endosomes, lysosomes, and autophagy, which determine their toxicity and therapeutic effectiveness. Understanding these processes is essential for designing safe and efficient nanomedicines. The review highlights the importance of optimizing NP properties to enhance their biological functions while minimizing cytotoxicity.